Clinical trial
Predictive Value of New AMH Test Method for Ovarian Response in Patients With IVF/ICSI
NCT04639505 is registered in ClinicalTrials.gov with Reproductive & Genetic Hospital of CITIC-Xiangya as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Value of New AMH Test Method for Ovarian Response in Patients With IVF/ICSI
- Lead sponsor
- Reproductive & Genetic Hospital of CITIC-Xiangya
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 15, 2020
- Completion date
- September 30, 2021
- Enrollment
- 454 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amh, infertility